Alpha Tau Medical Ltd

Company Profile

Alpha Tau Medical Ltd had its IPO on 2021-03-08 under the ticker symbol DRTS.

The company operates in the Healthcare sector and Biotechnology industry. Alpha Tau Medical Ltd has a staff strength of 94 employees.

Stock update

Shares of Alpha Tau Medical Ltd opened at $3.35 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.3 - $3.43, and closed at $3.34.

This is a -0.3% slip from the previous day's closing price.

A total volume of 9,451 shares were traded at the close of the day’s session.

In the last one week, shares of Alpha Tau Medical Ltd have slipped by -6.96%.

Alpha Tau Medical Ltd's Key Ratios

Alpha Tau Medical Ltd has a market cap of $325.60 million, indicating a price to book ratio of 2.2584 and a price to sales ratio of 0.

In the last 12-months Alpha Tau Medical Ltd’s revenue was $0 with a gross profit of $0 and an EBITDA of $-31157000. The EBITDA ratio measures Alpha Tau Medical Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Alpha Tau Medical Ltd’s operating margin was 0% while its return on assets stood at -24.74% with a return of equity of -47.07%.

In Q1, Alpha Tau Medical Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Alpha Tau Medical Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.13 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alpha Tau Medical Ltd’s profitability.

Alpha Tau Medical Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -4.7898. Its price to sales ratio in the trailing 12-months stood at 0.

Alpha Tau Medical Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$7.89 million

Total Liabilities

$337250.00

Operating Cash Flow

$0

Capital Expenditure

$226000

Dividend Payout Ratio

0%

Alpha Tau Medical Ltd ended 2025 with $7.89 million in total assets and $0 in total liabilities. Its intangible assets were valued at $7.89 million while shareholder equity stood at $-48250.00.

Alpha Tau Medical Ltd ended 2025 with $0 in deferred long-term liabilities, $337250.00 in other current liabilities, in common stock, $-4171750.00 in retained earnings and $0 in goodwill. Its cash balance stood at $457750.00 and cash and short-term investments were $7.03 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Alpha Tau Medical Ltd’s total current assets stands at $7.46 million while long-term investments were $0 and short-term investments were $6.57 million. Its net receivables were $141000.00 compared to accounts payable of $223250.00 and inventory worth $0.

In 2025, Alpha Tau Medical Ltd's operating cash flow was $0 while its capital expenditure stood at $226000.

Comparatively, Alpha Tau Medical Ltd paid $0 in dividends in 2025.

Other key metrics

Current Trading Price

$3.34

52-Week High

$12.5

52-Week Low

$2.75

Analyst Target Price

$15

Alpha Tau Medical Ltd stock is currently trading at $3.34 per share. It touched a 52-week high of $12.5 and a 52-week low of $12.5. Analysts tracking the stock have a 12-month average target price of $15.

Its 50-day moving average was $3.75 and 200-day moving average was $3.6 The short ratio stood at 2.7 indicating a short percent outstanding of 0%.

Around 4543.7% of the company’s stock are held by insiders while 164.9% are held by institutions.